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Introduction
Reducing hyperinflated diseased lung in patients suffering 
from inhomogeneous emphysema was introduced more 
than 50 years ago (1). Lung volume reduction (LVR) 
includes surgical methods, so-called lung volume reduction 
surgery (LVRS) and bronchoscopic lung volume reduction 
(BLVR).
Anaesthesia management for LVR procedures is 
challenging. Besides severe airway obstruction and impaired 
gas exchange, patients undergoing LVR often suffer from 
pre-existing comorbidity and their physical status of the 
American Society of Anaesthesiology classification is higher 
than three (2). The operation site and the mechanical 
ventilation are interdependent and lung protective 
mechanical ventilation of the previously diseased lung 
is crucial for the postoperative success of the procedure. 
Recovery of spontaneous breathing at the end of surgery 
and extubation are mandatory to reduce airway pressure (3). 
Implementation of a multimodal analgesia concept and 
the use short-acting anaesthetics enhanced recovery. In 
addition, optimal fluid therapy and active warming could 
achieve normovolemia and normothermia.
Anaesthesia for LVR is a challenge in these patients and 
should be performed by experienced consultants, since 
airway management for BLVR and LVRS is different and 
may be difficult: BLVR needs the sharing of the airway 
between interventionist and anaesthesiologist—LVRS needs 
one-lung-ventilation with lung separation. An algorithm for 
securing airway management should be established. Beyond 
the difference from established airway algorithms, training 
in difficult LVR airway management has been shown very 
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effective (4).
Preoperative management
Optimizing the patient’s condition before the LVR reduces 
postoperative complications and may be mandatory for 
successful treatment. First, assessment of individual patient 
risk factors before the planned intervention allows pre-
treatment optimization. Due to the risk factors and pre-
existing conditions of patients prior to the LVR, it is 
sometimes necessary to coordinate further interventions like 
coronary interventions prior to the LVR (5) recommended 
by American College of Cardiology/American Heart 
Association (ACC/AHA) guideline on perioperative 
cardiovascular evaluation and management of patients 
undergoing non-cardiac surgery (5). A recent transthoracic 
echocardiography should have been performed on each 
patient, especially to evaluate the right ventricular function. 
A systolic pulmonary arterial pressure (SPAP) >35 mmHg 
and with a homogeneous emphysema is considered as 
a contraindication for LVR (6). SPAP up to 45 mmHg 
in patients with heterogeneous emphysema and severe 
hyperinflation could be tolerable for LVR, although robust 
evidence is missing (6). 
Alcohol and smoking should be reduced and ceased 
preoperatively (7,8) to reduce the risk of infections, 
respiratory, and neurological complications and the 
intensive care unit (ICU) stay (9). Whether preoperative 
spirometry training is beneficial in patients undergoing 
thoracotomy and lung resection (10) and despite lacking 
data it should be recommended in patients for LVR. As 
preoperative medication for anxiolysis, benzodiazepines 
seem to have advantages over alpha-2-agonists (11). 
However, anxiolysis must be carefully weighed towards 
sedative and respiratory depressive effects especially in the 
LVR patient collective.
Anaesthesia management in LVRS
Strategy
The main strategy in anaesthesia management for LVR 
should be an effective analgesic concept with combined 
methods, lung protective ventilation and an evidence based 
concept of airway separation. Better pain control with 
thoracic epidural anesthesia (TEA) is established in a wide 
range of surgical procedures (12). A recent meta-analysis 
of the pulmonary effects of TEA showed a reduced rate of 
pneumonia after TEA, probably due to earlier mobilization, 
reduced opioid consumption, and improved cough (13). 
In the past, general anaesthesia and separated ventilation 
of the lungs were always necessary in thoracic surgery (1). 
The only way to perform lung-separation with one-lung 
ventilation has been a double-lumen tube or bronchus 
blockade. The bronchus blockade seemed to have 
disadvantages due to the over-inflated lungs of the patients 
undergoing LVR and has been rarely used (14). With the 
introduction of video-assisted thoracoscopic surgery other 
strategies such as non-intubated video-assisted thoracic 
surgery (NIVATS) may be an alternative concept, which 
has to been further proved to produce robust evidence by 
future well-designed studies (15). Without intubation, the 
spontaneously breathing patient develops a pneumothorax 
after surgical opening of the pleura, which may create 
sufficient operating conditions. However, the cough 
reflex must be prevented by surgical vagus blockade (16). 
The disadvantages are movements, conversion to open 
procedure, insufficient analgesia, panic attacks and 
respiratory complications (15,16). The conversion rate is 
described as less than 5% (15).
Anaesthetics
The selection of short-acting anaesthetics in combination 
with thoracic epidural analgesia is important to reduce 
postoperative complications. On one hand, postoperative 
complications such as nausea and vomiting can be reduced, 
on the other hand, the avoidance of anaesthesia overhang 
is essential (17). Remifentanil as a short-acting opioid with 
a very short context-sensitive half-life seems to be a valid 
choice for anaesthesia maintenance, but no data on opioid 
choice in LVR patient exist. Due to the short half-life time 
of remifentanil and therefore a lack of postoperative effect, 
it should only be used as part of a multimodal pain concept.
The necessity of muscle relaxation, especially for 
the suppression of intraoperative coughing, should be 
performed with reversible muscle relaxants. Clear data 
on the save use of cisatracurium exists, but after the 
introduction of a selective binding agent for reversal of 
neuromuscular blockade—sugammadex-rocuronium 
bromide may be an alternative. Since postoperative 
recurarization is a morbidity factor in anaesthesia, 
antagonization is mandatory. Rocuronium shows slight 
advantages through the introduction of sugammadex, 
especially when neostigmine related side effects count. 
There were no significant differences in a recent single 
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blind trial of 120 patients if both are antagonized with 
neostigmine (18). The use of neuromuscular monitoring 
for muscle relaxation is strictly recommended, to especially 
avoid respiratory complications in LVR patients.
The use of intravenous or inhaled anaesthesia has long 
been the subject of numerous studies. In a randomized 
controlled multicentre trial of Beck et al. with 460 patients 
addressing the effect of volatile versus intravenous 
anaesthetics on major complications after lung surgery 
no difference between the two anaesthesia regimens was 
evident (19,20). Importantly inhalational anaesthetics 
dose-dependently influence local inflammatory processes, 
partially reverse hypoxic pulmonary vasoconstriction and 
reduce alveolar clearance (19,21). Due to the short half-life 
time and faster recovery anaesthesia with desflurane seems 
to be a preferable option.
Lung protective ventilation
Lung injury is the leading cause of death after thoracic 
surgery. Protective ventilation may prevent postoperative 
lung injury and reduces postoperative pulmonary 
complications. Elements of lung protective ventilation are 
short duration of ventilation (i.e., one-lung ventilation), low 
FiO2, low tidal volume [4–5 mL/kg body weight (BW)], 
recruitment after induction and after one-lung ventilation 
and moderate positive end-expiratory pressure (PEEP) 
levels (5–10 cm H2O) (see Table 1) (22). 
Furthermore, permissive hypercapnia may be used to 
accelerate oxygen delivery during one-lung ventilation and 
in chronic obstructive pulmonary disease (COPD) patients 
with residual hyperinflation (3).
Lung protective ventilation has become an integral 
part of protocols to prevent pulmonary complications like 
pneumonia or accelerate the recovery time [e.g., enhanced 
recovery after surgery (ERAS)], which is both also, wanted 
in LVR (23-25).
One-lung-ventilation allows both open and video-assisted 
thoracic surgery. However, it also represents an independent 
risk factor for complications such as pneumonia, atelectasis 
and acute lung damage. 
The two key steps during LVRS are re-expansion and 
ventilation of the suspended lung and early extubation. Re-
expansion and ventilation of the operated lung should be 
carried out during lung separation because of the different 
compliance of both lungs. The concept ‘open the lung and 
keep it open’ could be a guide in re-ventilation although 
clear data for patients undergoing LVRS is missing (26). 
The extubation of patients with a double-lumen tube often 
leads to coughing, which may affect the outcome of the 
operation and lead to relevant pneumopleural fistula. For 
this reason, extubation of the patient in deep anaesthesia 
and relaxation, intubation with laryngeal mask (LM) second 
generation, transfer to spontaneous respiration and removal 
of the LM from the awake and spontaneously breathing 
patients should be recommended. 
Perioperative fluid management
The amount and quality of perioperative fluids applicated 
treads the tight line between hypovolemic complications, 
especially acute kidney injury and fluid overload of the 
lungs (27). The situation increases by the scarce pulmonary 
functional reserves of the LVR patients. Strong evidence 
exists for a normovolemic fluid regimen in thoracic surgery 
(Table 2). Balanced crystalloids are recommended, saline 
solutions should be avoided and colloids should only be 
used as a substitute for blood loss (23,25).
The integration of volume management into a “Patient 
Blood Management” tool shows many advantages 
Table 1 Parameters of lung protective ventilation in LVRS
Procedure Application Avoidance
Recruitment maneuver After induction/positioning and re-ventilation: PEEP 10–20 cmH2O, 
30–40 cmH2O, during 10–40 sec
Atelectasis, acute cor pulmonale
PEEP level During one-lung ventilation: 2 cmH2O PEEP High shunt volume
Tidal volume 4–6 mL/kg bodyweight; I:E =1:2.5 or longer expiration time Hyperinflation of bullae
Peak pressure <25 (maximum 30) cmH2O Barotrauma (pneumothorax)
FiO2 Normoxia: paO2 >14 kPa or like paO2 under FiO2 0.21 Free O2 radicals
I:E means inspiratory time : expiratory time. LVRS, lung volume reduction surgery; PEEP, positive end-expiratory pressure. 
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in the outcome of anaemic patients. It should start 
preoperatively with the substitution of ferritin, vitamin 
B12 or erythropoietin in patients with low haemoglobin 
levels <120 g/L in women and <130 g/L in men to avoid 
the intraoperative use of blood products (28). A blood 
coagulation management with bedside measurements 
should take place intraoperative and the administration of 
any blood products should be avoided (28).
Anaesthesia management for bronchoscopy, Chartis 
measurement and BLVR
The procedure of this combined intervention usually 
requires general anaesthesia with a possible mélange of 
different techniques in airway management and ventilation. 
Rigid bronchoscopy, endotracheal intubation, supraglottic 
airway (SGA) device, and jet ventilation catheters have 
been used for BLVR. In contrast to standard bronchoscopy, 
in which the bronchoscope remains in the airway during 
retrieval of the biopsy specimen, Chartis measurement and 
valve implementation requires multiple en bloc retrievals 
of the bronchoscope, the catheter and/or the device. This 
requires multiple re-navigations through the nose or mouth, 
may cause epistaxis, and recommends the use of airway 
protection.
The Chartis measurement, which is an endobronchial 
pulmonary assessment system, is the preferred and 
recommended method to measure collateral ventilation in 
spontaneous breathing or controlled mechanical ventilation 
with long expiration time and low frequency (29). 
Since SGA allows spontaneous breathing or controlled 
mechanical ventilation and SGA-related complications 
like mucosal trauma, hematoma, and arytenoid dislocation 
are rare compared to endotracheal intubation or rigid 
bronchoscopy (where additional equipment like jet 
ventilators are needed), SGA devices have numerous 
well-known advantages (30). The use of the i-gel SGA 
(Intersurgical Inc., Wokingham, UK) shows fewer 
complications (i.e., blood staining, sore throat, and 
dysphagia) compared to other SGA and commonly is used 
for therapeutic fiberoptic bronchoscopy (31-33). The airway 
channel cross-section of a size-5 i-gel SGA is elliptical 
and shows a major axis of 13.4 mm and a minor axis of 
12.9 mm (33). This results in a cross-section area of 137 mm2 
compared to 57 mm2 in a 8.5-I.D. orotracheal tube. The 
design of the i-gel®, a second-generation SGA with a wide 
airway channel, facilitates easy passage of the fiberoptic 
bronchoscope, providing a precise glottic view, easy Chartis 
measurement, and valve application (34).
To improve bronchoscopist’s conditions, general 
anaesthesia (using remifentanil, propofol and mivacurium) 
with an i-gel SGA device should be used for BLVR. Jet 
ventilation through rigid bronchoscopy or with a jet 
catheter alone may be an alternative concept (respiratory 
frequency 15–100 breaths/min, inspiratory pressure 150–
250 kPa) (35).
Table 2 Perioperative fluid management
Pre-interventional Intraoperative Post-operative
	 Goal: 	 Goal directed therapy (GDT) 	 No intravenous (IV)-fluid
	 Fluid?	 No sodium or fluid overload	 Normovolemia
	 Normal weight 	 Substitution maintenance: 	 Maintenance?
	 Avoid hypothermia 	 2 mL/kg/h 	 Substitution?
	 Period of rest: 	 Balanced infusion 	 Resuscitation?
	 2-h fluid 	 Normothermia
	 6-h solid 	 Avoid hypovolemia, hypoperfusion and 
fluid overload
	 Prophylaxis of thrombosis 	 Hb >7 g/dL
	 Careful use of vasopressors	 Incentive spirometry
	 Coaching
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Postanaesthesia management
Postinterventional monitoring should detect adverse 
events like cardiovascular complications (i.e., arrhythmia), 
pulmonary events (i.e., exacerbation, infection, respiratory 
failure, and pneumothorax) or valve-related events (i.e., 
expectoration, migration, aspiration). A 24-h hospitalization 
on an intermediate care unit may be suggested.
Conclusions
Anaesthesia plays a key role in the perioperative treatment 
of patients undergoing LVR. Due to lack of evidence 
common strategies of anaesthesia in thoracic surgery 
combined with new procedures can successfully be applied. 
Deep general anaesthesia and one-lung ventilation through 
a double-lumen tube are the gold standard in the LVRS, 
SGA device in the BLVR. New methods like NIVATS are 
gaining more importance but needs evidence (36).
In the perioperative treatment, the anaesthesiologist 
can contribute to the result through accurate patient 
preparation and effective multimodal pain therapy.
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